Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: An audit of an evidence-based empiric antimicrobial policy

South African Medical Journal

Volumn 103, Issue 6, 2013, Pages 371-376

  Ramsamy, Y ^a,b   Muckart, D J J ^a   Han, K S S ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFOXITIN; CIPROFLOXACIN; CLOXACILLIN; FLUCONAZOLE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER; ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; COLONY FORMING UNIT; DISEASE SURVEILLANCE; FEMALE; HOSPITAL INFECTION; HUMAN; INJURY; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL SURVEILLANCE; PRESCHOOL CHILD; SCHOOL CHILD; SEPSIS; SURGICAL INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SOUTH AFRICA;

EID: 84878363533     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.6459     Document Type: Article

References (22)

1. Brink A, Coetzee J, Clay C, et al. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention. S Afr J Med 2012;102:599-601.
2. Mendelson M, Whitelaw A, Nicol M, Brink A. Wake up South Africa! The antibiotic 'horse' has bolted. S Afr J Med 2012;102:607-608.
3. Paruk F, Richards G, Scribante J, et al. Antibiotic prescription practices and their relationship to outcome in South African intensive care units: Findings of the Prevalence of Infection in South African Intensive Care Units (PISA) Study. S Afr J Med 2012;102:613-616.
4. Wagh H, Acharya D. Ventilator associated pneumonia - An overview. British Journal of Medical Practitioners 2009;2(2):16-19.
5. Lynch JP. Hospital-acquired pneumonia. Risk factors, microbiology, and treatment. Chest 2001;119:373S-384S. [http://dx.doi.org/10.1378%2Fchest.119.2_suppl.373S]
6. Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: Mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin 2011;27:163-205. [http://dx.doi.org/10.1016%2Fj.ccc.2010.11.002]
7. Rahall JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance to nosocomial Klebsiella. JAMA 1998;280:1233-1237. [http://dx.doi.org/10.1001%2Fjama.280.14.1233]
8. Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 2006;43:S82-S88. [http://dx.doi.org/10.1086%2F504484]
9. Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit. Am J Resp Crit Care Med 2009;179:434-438. [http://dx.doi.org/10.1164%2Frccm.200809-1394CP]
10. Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Annals of Intensive Care 2011;1:47-53. [http://dx.doi.org/10.1186%2F2110-5820-1-47]
11. Derensinski S. Principles of antimicrobial therapy in severe infections: Optimizing the therapeutic approach by use of laboratory and clinical data. Clin Infect Dis 2007; 45:S177-183.
12. NHLS. Q-pulse Standard Operating Procedures. Q-pulse 5/docs/active/MIC 1569v1, MIC 1587v1, MIC 1840vi, MIC 1849v1. Johannesburg: NHLS, 2010 (accessed 15 December 2012).
13. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12. [http://dx.doi.org/10.1086%2F595011]
14. Dhillon RH, Clark J. ESBLs: A clear and present danger? Crit Care Res Pract 2012. Published online 6 June2011. [http://dx.doi.org/10.1155/2012/625170]
15. Rosenberger LH, LaPar DJ, Sawyer RG. Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: The 20,000 foot view. J Am Coll Surg 2012;214:747-755. [http://dx.doi.org/10.1016%2Fj.jamcollsurg.2012.01.040]
16. Lepak A, Andes D. Fungal sepsis: Optimizing antifungal therapy in the critical care setting. Crit Care Clin 2011;27:123-147. [http://dx.doi.org/10.1016%2Fj.ccc.2010.11.001]
17. Murray CK, Hospenthal DR. Acinetobacter infection in the ICU. Crit Care Clin 2008;24:237-248. [http://dx.doi.org/10.1016%2Fj.ccc.2007.12.005]
18. Russo TA, Luke NR, Beanan JN, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010;78:3993-4000. [http://dx.doi. org/10.1128%2FIAI.00366-10]
19. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001;29:1473-1475. [http://dx.doi.org/10.1097%2F00003246-200107000-00029]
20. Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011;86:1113-1123. [http://dx.doi. org/10.4065%2Fmcp.2011.0358]
21. Fleming A. History and Development of Penicillin. In: Penicillin. Fleming A, ed. London: Butterworth and Co., 1946:1-23.
22. Porritt AE, Mitchell GAG. Prophylactic Use of Penicillin. In: Penicillin. Fleming A, ed. London: Butterworth and Co., 1946:105-115.